This Article Full Text (PDF) Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vallis, K A Articles by Kerr, G R Search for Related Content PubMed PubMed Citation Articles by Vallis, K A Articles by Kerr, G R

Radiotherapy for Stages I and II testicular seminoma: results and morbidity in 238 patients

Department of Clinical Oncology, Western General Hospital, Edinburgh EH4 2XU, UK

We have undertaken a retrospective analysis of 238 patients with Stages I and II seminoma of the testis treated with radiotherapy in Edinburgh between 1974 and 1989. There were five deaths from seminoma. Cause-specific survival for the whole group at 2 and 5 years was 99.2% and 98.1%, respectively. Causespecific survival at 2 and 5 years by stage (Royal Marsden staging classification) was: Stage I, 99.5% and 98.7% and Stage II, 98.1% and 96.1%. Fourteen (5.9%) patients relapsed (one after treatment for his second testicular seminoma). Eight were given successful salvage treatment, five died of seminoma and one died of intercurrent disease. 13 (5.5%) patients developed World Health Organisation (WHO) grade 3 gastrointestinal or haematological toxicity and two developed grade 4 gastrointestinal toxicity as a result of abdominal radiotherapy. 22 patients (9.2%) developed problems ascribed to late morbidity of abdominal radiotherapy including 18 with peptic ulcer disease. Contralateral testicular tumours occurred in seven (2.9%) patients and five (2.1%) patients developed malignancies at other sites.

^* Current address: Imperial Cancer Research Fund Clinical Oncology Unit, University of Oxford, Churchill Hospital, Oxford OX3 7LJ, UK.

Received for publication August 8, 1994. Revision received October 10, 1994. Accepted for publication October 20, 1994.

This article has been cited by other articles:

				S. D. Fossa, E. Gilbert, G. M. Dores, J. Chen, K. A. McGlynn, S. Schonfeld, H. Storm, P. Hall, E. Holowaty, A. Andersen, et al. Noncancer Causes of Death in Survivors of Testicular Cancer J Natl Cancer Inst, April 4, 2007; 99(7): 533 - 544. [Abstract] [Full Text] [PDF]

				H. J. Schmoll, R. Souchon, S. Krege, P. Albers, J. Beyer, C. Kollmannsberger, S. D. Fossa, N. E. Skakkebaek, R. de Wit, K. Fizazi, et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG) Ann. Onc., September 1, 2004; 15(9): 1377 - 1399. [Abstract] [Full Text] [PDF]

				J. Classen, H. Schmidberger, C. Meisner, R. Souchon, M.-L. Sautter-Bihl, R. Sauer, S. Weinknecht, K.-U. Kohrmann, and M. Bamberg Radiotherapy for Stages IIA/B Testicular Seminoma: Final Report of a Prospective Multicenter Clinical Trial J. Clin. Oncol., March 15, 2003; 21(6): 1101 - 1106. [Abstract] [Full Text] [PDF]

				S. D. Fossa, N. Aass, M. Winderen, O. P. Bormer, and D. R. Olsen Long-term renal function after treatment for malignant germ-cell tumours Ann. Onc., February 20, 2002; 13(2): 222 - 228. [Abstract] [Full Text] [PDF]